Table: Kringle Pharma -2020/21 parent results

Kringle Pharma

12/11/2021 06:30

Nov 12 (Reuters)- 
          Kringle Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended        Year to         NEXT   
              Sep 30, 2021     Sep 30, 2020     Sep 30, 2022      YEAR     
                 LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS         RESULTS          FORECAST     H1 FORECAST 
  Sales          289 mln         467 mln          355 mln                  
               (-38.0 pct)                      (+22.6 pct)                
  Operating   loss 357 mln     loss 171 mln      loss 1.36                 
  Recurring   loss 299 mln     loss 116 mln      loss 1.30                 
  Net         loss 301 mln     loss 117 mln      loss 1.30                 
  EPS        loss 72.51 yen  loss 106.70 yen  loss 299.22 yen              
  Ann Div          NIL             NIL              NIL                    
  -Q2 Div          NIL                              NIL                    
  -Q4 Div          NIL             NIL              NIL                    
  
  NOTE - Kringle Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4884.T